Navigation Links
Researchers win money to develop breath test to detect breast cancer

One of the biggest problems in fighting breast cancer is the lack of inexpensive, early detection diagnostic tools.

Researchers at the University of Michigan hope to change that by developing a device to test breath for the presence of metabolites associated with breast cancer. The team won a Breast Cancer Research Program Idea award, which funds promising, high-risk, high reward research proposals that could lead to critical advancements in eradicating breast cancer.

"We are very excited about getting this grant without having had too much real exposure to breast cancer research," said Joerg Lahann, assistant professor of chemical engineering and principal investigator. Lahann's team was funded for $446,731 over three years. Lahann also has appointments in biomedical engineering, materials science and engineering, and macromolecular science and engineering. The research is funded by the Department of Defense.

The cornerstone of the device, and what makes it possible, is the switchable surface technology developed in Lahann's lab while a post doctoral student at MIT. Together with professor Robert Langer, they published their findings in the journal Science in 2003. Lahann came to U-M in 2003, and his lab is extending the technology into applications.

The IDEA proposal states that the switchable surfaces have molecularly designed sites that will attract certain metabolites indicative of breast cancer. These sites are actually little nanopockets about 6.4 nm2 in size, that interact with oil and water. The metabolites are also very small and they are attracted to the oil and water pockets.

The switchable surfaces can be engineered to stand up or lie down---imagine blades of tall grass before a strong wind blows them flat. The surfaces switch when electrical charges are applied to make the straight particles bend. When upright, the spaces between the particles are open, and will attract the metabolites.

Theoretically , a woman could breathe into an over-the-counter device and cancer-indicating metabolites would be attracted into the nanopockets, thus causing the pored surface to fill and become dense. Then, an electrical charge would be applied so that the straight particles would bend, thus ejecting the metabolites so that multiple tests could be done in the same device. You can detect the metabolites through a change in conductance or optically

The idea materialized when Lahann's graduate student David Pang found two papers that showed certain molecules, called metabolites that could mark breast cancer, are present in breath and urine.

"We realized that if one could put these molecules in a screening platform, they might develop a non-invasive, quick and inexpensive over-the-counter breast cancer screening test," Lahann said.


'"/>

Source:University of Michigan


Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Researchers find how protein allows insects to detect and respond to pheromones
3. Researchers Uncover Key Step In Manufacture of Memory Protein
4. Researchers reveal the infectious impact of salmon farms on wild salmon
5. Researchers identify target for cancer drugs
6. Researchers discover molecule that causes secondary stroke
7. Researchers find missing genes of ancient organism
8. Researchers trace evolution to relatively simple genetic changes
9. Researchers add new tool to tumor-treatment arsenal
10. UF Researchers Map Bacterial Proteins That Cause Tooth Loss
11. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... California (PRWEB) , ... October 10, 2017 , ... Dr. ... speaking at his local San Diego Rotary Club. The event entitled ... Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined by ...
(Date:10/10/2017)... CRUZ, Calif. , Oct. 10, 2017 ... grant from the NIH to develop RealSeq®-SC (Single Cell), ... kit for profiling small RNAs (including microRNAs) from single ... Analysis Program highlights the need to accelerate development of ... "New techniques for measuring ...
Breaking Biology Technology: